- ►physiology.org MG Clark - American Journal of Physiology- Endocrinology And …, 2008 - Am Physiological Soc Insulin has an exercise-like action to increase microvascular perfusion of
skeletal muscle and thereby enhance delivery of hormone and nutrient to the
myocytes. With insulin resistance, insulin's action to increase ... Cited by 9 - Related articles - All 7 versions
KP Garnock-Jones, GL Plosker - Drugs, 2009 - ingentaconnect.com Various sections of the manuscript reviewed by: DSH Bell, Division of
Endocrinology and Metabolism, University of Alabama at Birmingham, Birmingham,
Alabama, USA; BW Bode, Atlanta Diabetes Associates, Atlanta, Georgia, USA; ... Related articles - All 3 versions
S Fordan, P Raskin - Vascular Health and Risk Management, 2009 - pubmedcentral.nih.gov The insulin analogs lispro, aspart, and glulisine are the only commercially
available rapid-acting insulins to treat diabetes. We review the evidence for
treating hyperglycemia, using insulin, and specifically using rapid-acting ... Related articles - All 6 versions
F Schliess, T Heise - Therapy, 2009 - Future Medicine Insulin glulisine (glulisine) is a new fast-acting human insulin analogue
approved for treatment of diabetes Type 1 and 2. Preclinical investigations
indicate mitogenic and metabolic potency similar to human insulin, but ... Related articles - All 3 versions
P ITT, P PP - genesis.sefh.es Justificación de la solicitud: consigue un pico de acción claramente más
rápìdo que la insulina regular y discretamente más rápido que los análogos
lispro y aspart, sobre todo en pacientes obesos. No contiene Zinc. Related articles - View as HTML